Ibrutinib Hemifumarate - Request Quote
Ibrutinib Hemifumarate
| SZ CAT No: | SZ-I005068 |
| CAS No | NA |
| Mol.F. | C25H24N6O2 : 1/2(C4H4O4) |
| Mol.Wt. | 440.5 : 1/2(116.1) |
| Inv. Status | In Stock |
| Rel. CAS No | 936563-96-1 (free base) |
| Shipping Condition | Room Temperature |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ibrutinib Hemifumarate is chemically (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one hemifumarate. It is also known as Ibrutinib R-Isomer. Ibrutinib Hemifumarate is supplied with detailed characterization data compliant with regulatory guideline. Ibrutinib Hemifumarate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ibrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Ibrutinib Hemifumarate
Purchase Ibrutinib Hemifumarate
Ibrutinib Hemifumarate suppliers
Ibrutinib Hemifumarate manufacturers
Ibrutinib Hemifumarate price
Order Ibrutinib Hemifumarate
Enquire Ibrutinib Hemifumarate
Ibrutinib Hemifumarate cost
Ibrutinib Hemifumarate Supplier
Ibrutinib Hemifumarate Distributor
Ibrutinib Hemifumarate for Method Validation
Ibrutinib Reference Standard
Ibrutinib Hemifumarate for ANDA Filing
Ibrutinib Hemifumarate for Forced Degradation Studies
Ibrutinib Hemifumarate Identification Standards
Ibrutinib Hemifumarate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


